National Institutes of Health, National Institute of Allergy and Infectious Diseases, Contract Management Branch, Solar Bldg., Room 3C07, 6003 Executive Blvd. MSC 7610, Bethesda, MD 20892-7610

A -- TUBERCULOSIS TECHNOLOGY TRANSFER SUPPORT SOL RFP-NIH-NIAID-DAIDS-99-17 DUE 111398 POC Ms. Joyce U. Sagami, Contract Specialist, 301-496-7118 The Opportunistic Infections Research Branch, Therapeutics Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), NIH, has a requirement to develop therapies for the treatment of AIDS and associated opportunistic infections. The purpose of this RFP is to seek responsible offers for new tuberculosis drug technology development and transfer support. This contract is to serve as a resource for facilitating the translation of anti-tuberculosis discoveries into candidates for development and commercialization. RESTRICTIONS TO COMPETITION This contract will involve the use of information on compounds, which may be confidential and proprietary. All offerors except those deemed by the Government to have an actual or apparent conflict of interest are eligible to compete. Organizations that are, or subsidiaries to, pharmaceutical or chemical companies (i.e., an organization which sells drugs and/or chemicals to the general public for profit) are examples of organizations that are excluded from competition. Documentation of commercial interests, such as investors' prospectus or recent audit, must be supplied in an offeror's business proposal. The Government reserves the right to exclude any offeror. If there is ANY question about potential conflicts or APPARENT conflicts, contact the Contracting Officer. An Advance Understanding will be inserted in the resultant contract stating that the NIAID shall be notified if the Contractor's conflict of interest status has changed and that a determination shall be made regarding the continuation of the contract. It is anticipated that one cost reimbursement, completion type contract will be awarded for a period of seven (7) years, beginning approximately August 17, 1999. RFP NIH-NIAID-DAIDS-99-17 will be available electronically on or about August 6, 1998, and may be accessed through the NIAID Contract Management Branch (CMB) Home Page by using the following electronic address and instructions: NIAID/CMB Home Page (via the WWW): Use http://www.niaid.nih.gov/contract to access the NIAID/CMB Home Page. Once at the NIAID/CMB Home Page, click on the "RFPs" link and then click on "RFP NIH-NIAID-DAIDS-99-17." Please note that the RFP for this acquisition has been revised to include only the Work Statement, Deliverable and Reporting Requirements, Special Requirements and Mandatory Qualification, if any, the Technical Evaluation Criteria, and the Proposal Preparation Instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range will be requested to provide additional documentation to the Contracting Officer. Responses to this RFP will be due on November 13, 1998. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Joyce U. Sagami, Contract Specialist Electronic mail address: js73b@nih.gov Telephone: (301) 496-7118 FAX: (301) 402-0972 No collect calls will be accepted. Posted 07/30/98 (W-SN230474). (0211)

Loren Data Corp. http://www.ld.com (SYN# 0009 19980803\A-0009.SOL)